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ABSTRACT
Objectives Bacterial vaginosis (BV) is characterised by
a change in the microbial composition of the vagina.
The BV-associated organisms outnumber the health-
associated Lactobacillus species and form a polymicrobial
bioﬁlm on the vaginal epithelium, possibly explaining the
difﬁculties with antibiotic treatment. A better
understanding of vaginal bioﬁlm with emphasis on
Atopobium vaginae and Gardnerella vaginalis may
contribute to a better diagnosis and treatment of BV.
Methods To this purpose, we evaluated the
association between the presence of both bacteria by
ﬂuorescence in situ hybridisation (FISH) and BV by
Nugent scoring in 463 vaginal slides of 120 participants
participating in a clinical trial in Rwanda.
Results A bacterial bioﬁlm was detected in half of the
samples using a universal bacterial probe. The bioﬁlm
contained A. vaginae in 54.1% and G. vaginalis in
82.0% of the samples. A. vaginae was accompanied by
G. vaginalis in 99.5% of samples. The odds of having a
Nugent score above 4 were increased for samples with
dispersed G. vaginalis and/or A. vaginae present (OR
4.5; CI 2 to 10.3). The probability of having a high
Nugent score was even higher when a combination of
adherent G. vaginalis and dispersed A. vaginae was
visualised (OR 75.6; CI 13.3 to 429.5) and highest
when both bacteria were part of the bioﬁlm (OR 119;
CI 39.9 to 360.8).
Conclusions Our study, although not comprehensive at
studying the polymicrobial bioﬁlm in BV, provided a
strong indication towards the importance of A. vaginae
and the symbiosis of A. vaginae and G. vaginalis in this
bioﬁlm.
Trial registration number NCT01796613.
INTRODUCTION
Bacterial vaginosis (BV) is the most prevalent
vaginal disorder in women of reproductive age. It
increases the risk of acquisition and transmission of
sexually transmitted infections, including HIV, and
is associated with preterm birth in pregnant
women.1–3 The condition is characterised by a
change in the microbial composition of the vagina:
the Lactobacillus spp., associated with a healthy
vaginal microbiome, are outnumbered by micro-
aerophilic and anaerobic organisms, including
Gardnerella vaginalis.3–7 The mere presence of
G. vaginalis, however, is not sufﬁcient for the diag-
nosis of BV using traditional diagnostic algorithms
(see below) because many women without BV also
have G. vaginalis in their vaginal microbiome.4 BV
is, however, associated with high counts of G. vagi-
nalis using molecular methods and/or the presence
of a G. vaginalis-containing polymicrobial
bioﬁlm.4–10 Due to its strong adherence to vaginal
epithelial cells and bioﬁlm-forming capacities, it
has been suggested that G. vaginalis initiates the
colonisation of the vaginal epithelium and serves as
a scaffolding to which other species subsequently
can attach.10–12
One of the species that might attach to the
bioﬁlm initiated by G. vaginalis could be
Atopobium vaginae.13–14 Several molecular studies
have indicated a probable role for A. vaginae in
BV,14–16 and it has also been suggested that
A. vaginae plays a major part in the establishment
of a bioﬁlm, together with G. vaginalis.9 10
Considering it has been found in 80–90% of cases
of relapse17 and some strains have been shown in
vitro to be metronidazole resistant,18 it could be of
importance in the recurrence of BV after standard
treatment with metronidazole.
The current gold standard in BV research is the
microscopic evaluation and scoring of vaginal slides
according to Nugent.19 The diagnosis of BV is
based on the absence of lactobacilli and the pres-
ence of small Gram-negative to Gram-variable rods
(G. vaginalis and Bacteroides spp. morphotypes)
and curved Gram-negative rods (Mobiluncus spp.
morphotypes). In fact, bacterial bioﬁlm can also be
seen with this method in the form of clue cells,
which are vaginal epithelial cells covered by layers
of adherent Gram-negative and/or Gram-variable
cells, that is, bioﬁlms.20 Using Gram staining, it is
impossible to distinguish between the different bac-
terial species in the bioﬁlm. By labelling the cells
with a ﬂuorescent probe, using ﬂuorescence in situ
hybridisation (FISH), the structure and compos-
ition of the bioﬁlm can be studied in more detail.
To study the potential role of A. vaginae and the
synergy between A. vaginae and G. vaginalis in the
bioﬁlm, we used our newly developed peptide
nucleic acid (PNA) A. vaginae probe11 together
with an existing probe for G. vaginalis21 and a uni-
versal bacterial probe22 to investigate the compos-
ition of vaginal bioﬁlm and its importance in BV.
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MATERIALS AND METHODS
Clinical samples
Vaginal sample collection and preparation
Vaginal samples were collected from 120 women participating
in a clinical trial at Rinda Ubuzima in Kigali, Rwanda, studying
the safety and acceptability of a contraceptive vaginal ring
(Nuvaring), including the effect of the vaginal ring on the
vaginal microbiome (the Ring Plus study—Clinicaltrials.gov
NCT01796613).23 Participants were between 18 and 35 years
old and provided written informed consent for participation in
the study. Depending on the group (continuous or intermittent
ring use) to which the participant was randomised, a total of
four or ﬁve samples from the same participant were taken over
a period of four menstrual cycles. A total of 463 samples were
analysed after Gram stain and after FISH using light microscopy
and confocal laser scanning microscopy (CLSM), respectively.
Vaginal sampling was carried out by the study physician during
a speculum examination in the Rinda Ubuzima research clinic. A
cotton swab was brushed against the lateral walls of the vagina and
was transported in its container to the Rinda Ubuzima laboratory
within 20 min. Upon arrival in the laboratory, the swab was used
to prepare a vaginal slide on a regular glass slide for Gram stain
and a second vaginal slide on a Superfrost Plus slide
(Menzel-Gläser, Braunschweig, Germany). All slides were air-
dried, heat-ﬁxed by passing through a ﬂame twice and then stored
in their appropriate boxes until Gram staining and/or shipment for
FISH. The ﬁrst slide was Gram stained and examined on-site in
the Rinda Ubuzima laboratory in Kigali. The Superfrost Plus slides
were stored and shipped at room temperature to the ITM where
they were ﬁxed for a minimum of 12 h in Carnoy solution (6:3:1,
ethanol:chloroform:glacial acetic acid).11
Microbiological analysis of the vaginal samples
Peptide nucleic acid ﬂuorescence in situ hybridisation
PNA FISH was performed as described earlier11 using species-
speciﬁc probes for A. vaginae (AtoITM1) and G. vaginalis
(Gard162) and the broad-range BacUni-1 probe. The hybridised
samples were stored in the dark at room temperature for a
maximum of 1 week before microscopic observation, using
CLSM (LSM700, Zeiss, Oberkochen, Germany). Detection and
identiﬁcation of individual bacteria were done at 400× magniﬁ-
cation (objective: Plan-Apochromat 40x/1.3 Oil Ph3 M27).
Separate scattered bacterial cells were deﬁned as dispersed bac-
teria. Aggregates of bacterial cells, sticking to the vaginal epithe-
lial cells, were deﬁned as adherent bacteria forming a bioﬁlm.
The species-speciﬁc signal was considered positive only if it had
a positive counterpart in the 4’,6-diamidino-2-phenylindole
(DAPI) stain and if it displayed a positive signal simultaneously
with the universal probe. Semi-quantiﬁcation was done for the
dispersed and adherent bacteria in three categories (absent,
present in low amount, present in high amount), but for the
analysis only two categories (absent or present) have been used.
Nugent score
The status of the vaginal microbiome was assessed at the Rinda
Ubuzima laboratory by Nugent scoring of a Gram stained
vaginal slide.19 A score of 0–3 was considered normal vaginal
microbiome; a score of 4–6 intermediate microbiome and a
score of 7–10 BV.
Statistical analysis
The clinical study sample size calculation was based on the
primary objective to assess the pre–post changes in the vaginal
microbiome and required 60 women in each group to require
95% power to detect clinically important changes in bacterial
counts.23 Data analysis was done using STATA10 (StataCorp LP,
Texas, USA). While the samples were collected longitudinally,
they were analysed cross-sectionally, with each sample as the
unit of analysis. To study the association between the presence
and absence of dispersed and/or adherent A. vaginae and adher-
ent G. vaginalis in relation to BV status, we categorised the
samples into ﬁve categories (table 1) based on combinations of
the presence of both bacteria in dispersed and/or adherent form
as visualised by FISH. To increase the statistical power, we made
the vaginal microbiome status binary: Nugent score 0–3 (refer-
ence group) versus Nugent score 4–10 (table 2). A mixed-effects
logistic regression model was ﬁtted with BV as the binary
outcome (ie, Nugent 0–3 vs Nugent 4–10) and bioﬁlm
characteristics as the main dependent variable. The model was
adjusted for woman, randomisation group and study visit,
because multiple samples per woman at multiple study visits
were included in the analysis. ORs are reported with 95% CI
and the p values are from χ2 tests (table 2).
RESULTS
Characterisation of vaginal samples
In total, 463 of 527 samples from 120 women were available for
FISH analysis, excluding 13 missing samples and 51 samples not
readable due to the absence of epithelial cells on the slides. In all
463 samples, a positive signal was detected for the universal
BacUni-1 probe. In 230 samples (49.7%), only dispersed bacteria
were present, while the other 233 slides (50.3%) contained
adherent bacteria as well (table 1). A. vaginae and G. vaginalis
were part of this bioﬁlm in 126 (54.1%) and 191 (82.0%)
samples, respectively. Next, we visualised A. vaginae with FISH
Table 1 Gardnerella vaginalis, Atopobium vaginae and G.
vaginalis with A. vaginae combinations for samples analysed with
fluorescence in situ hybridisation (FISH) by absent, dispersed only
and adherent ±dispersed category and stratified by Nugent scoring
Total
Nugent
0–3
Nugent
4–6
Nugent
7–10
N N (%) N (%) N (%)
FISH all bacteria
Absent 0 0 (0.0) 0 (0.0) 0 (0.0)
Dispersed only 230 197 (76.0) 19 (39.6) 14 (9.0)
Adherent ± dispersed 233 62 (24.0) 29 (60.4) 142 (91.0)
FISH A. vaginae (Av)
Absent 268 201 (77.6) 24 (50.0) 43 (27.6)
Dispersed only 69 41 (15.8) 10 (20.8) 18 (11.5)
Adherent ± dispersed 126 17 (6.6) 14 (29.2) 95 (60.9)
FISH G. vaginalis (Gv)
Absent 172 155 (59.8) 8 (16.7) 9 (5.8)
Dispersed only 100 71 (27.4) 15 (31.2) 14 (9.0)
Adherent ± dispersed 191 33 (12.8) 25 (52.1) 133 (85.2)
FISH Av and Gv combined
Gv and Av absent 170 153 (59.1) 8 (16.7) 9 (5.7)
Gv or Av dispersed only 101 72 (27.8) 15 (31.2) 14 (9.0)
Gv adherent ± Gv dispersed
and Av absent
51 14 (5.4) 8 (16.7) 29 (18.6)
Gv adherent ± Gv dispersed
and Av dispersed
15 3 (1.1) 3 (6.2) 9 (5.8)
Gv and Av adherent ± Gv
and Av dispersed
126 17 (6.6) 14 (29.2) 95 (60.9)
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in 195 (42.1%) samples; in 69 samples (14.9% of the total 463
samples) A. vaginae was present in a dispersed state, whereas in
126 samples (27.2%) the A. vaginae bacteria were seen adherent
to epithelial cells (table 1). For 122 (97.0%) of the samples with
adherent A. vaginae, concurrent dispersed A. vaginae bacteria
were observed. G. vaginalis was detected by FISH in 291
(62.9%) samples; it was detected as dispersed-only G. vaginalis
in 100 samples (21.6% of the total 463 samples) and for the
remaining 191 samples (41.3%) G. vaginalis was adherent to the
epithelial cells. Furthermore, when combining the results of both
bacteria and considering only the 291 G. vaginalis FISH-positive
samples, A. vaginae was absent in 98 of the slides (33.7%). On
the contrary, only two (0.5%) of the 195 samples showing A.
vaginae (dispersed and/or adherent) with FISH were negative for
G. vaginalis; this included one sample with adherent A. vaginae.
One-third of the vaginal samples (n=156; 33.7%) was classi-
ﬁed as Nugent score 7–10, 10% as Nugent score 4–6 (n=48;
10.4%) and the remaining 259 samples (55.9%) as Nugent 0–3.
The majority of the samples without A. vaginae (n=201;
75.0%) and without G. vaginalis (n=155; 90.1%) were cate-
gorised as Nugent 0–3, thus indicating a healthy microbiome. A
BV microbiome, deﬁned by a Nugent 7–10 category, was
present in 75.4% of samples with adherent A. vaginae (n=95)
and in 69.6% of the slides with adherent G. vaginalis (n=133).
In case of absent G. vaginalis and A. vaginae by FISH (n=170,
36.7%), a healthy microbiome (Nugent 0–3) was observed for
90.0% of the 170 samples (n=153). Furthermore, when consid-
ering G. vaginalis and A. vaginae adherent samples only
(n=126), 75.4% of the samples were categorised as BV (Nugent
7–10) (FISH experiments in ﬁgure 1; table 1).
The presence of A. vaginae, G. vaginalis and combinations
of both bacteria in dispersed and adherent forms in relation
to BV status
The group of FISH samples without A. vaginae and G. vaginalis
was used as the reference group (table 2). Compared with this ref-
erence group, the odds of having a Nugent score of 4–10 were
increased when one or both bacteria were present in the dispersed
state without adhering to the vaginal epithelium (OR 4.5 (CI 2 to
10.3)); it was increased further when G. vaginalis was part of an
adherent bioﬁlm on the epithelium (OR 49.2 (CI 15.9 to 151.8))
and even more when dispersed A. vaginae accompanied this G.
vaginalis bioﬁlm (OR 75.6 (CI 13.3 to 429.5)); ultimately the OR
was highest when A. vaginaewas part of the G. vaginalis bioﬁlm as
well (OR 119 (CI 39.9 to 360.8)).
DISCUSSION
We set out to study the potential role of A. vaginae in BV and
the synergy between A. vaginae and G. vaginalis in the
BV-associated bioﬁlm.
Our study conﬁrms that both A. vaginae and G. vaginalis are
important constituents of the vaginal epithelial bioﬁlm.9 11
Adherent A. vaginae and G. vaginalis were visualised in, respect-
ively, 54.1% and 82.0% of samples with bacterial bioﬁlm
(detected using the universal BacUni-1 probe), suggesting an
important role for both bacteria in this polymicrobial bioﬁlm.
Using FISH, we only found two samples containing A. vaginae
(dispersed in both, adherent in one) in the absence of G. vagina-
lis, while more than one-third of the G. vaginalis-positive
samples was negative for A. vaginae. This is in accordance with
prior reports on the association of A. vaginae with G. vagina-
lis.9 11 15 16 24 We showed that the presence of both bacteria in
the samples, regardless of their existence in a bioﬁlm, was asso-
ciated with an elevated or high Nugent score indicative for
vaginal dysbiosis and BV. The highest probability of having a
Nugent score higher than 3 was seen when both A. vaginae and
G. vaginalis were part of a bioﬁlm attaching to the vaginal epi-
thelial cells.
The association of G. vaginalis with BV was originally
described in 1954 by Gardner and Dukes.25 The involvement of
A. vaginae in BV, however, has only been established 10 years
ago.13–15 Swidsinski et al9 found vaginal biopsies with vaginal
bioﬁlm to be positive for G. vaginalis and A. vaginae when
using ﬂuorescent probes, although in our hands this A. vaginae
probe cross-reacted with other vaginal species as well.11
The presence of A. vaginae in the BV-associated bioﬁlm could
have a major impact on treatment. Susceptibility to metronida-
zole, the standard treatment for BV, varied signiﬁcantly across
various A. vaginae strains in vitro.18 In vivo data are scarce, but
Bradshaw et al17 found that rates of recurrence of BV were
higher when A. vaginae was present in the vaginal microbiome
in addition to G. vaginalis. In another study with topical metro-
nidazole gel by Ferris et al,13 it was shown that a high concen-
tration of A. vaginae before treatment was associated with
complete or partial failure of treatment for BV. In the above
studies, no distinction was made between dispersed and
bioﬁlm-associated bacteria. Nevertheless, as bacteria in a bioﬁlm
are less sensitive to antibiotic treatment26 and considering the
evidence from our study that the formation of a bacterial
bioﬁlm is more likely to occur when A. vaginae is present in the
vaginal microbiome, future design of studies may want to take
this distinction into account when treating BV.
Our study has shed new light on the signiﬁcance of
A. vaginae and the synergy between A. vaginae and G. vaginalis
in vaginal dysbiosis, using highly speciﬁc PNA probes for both
bacteria. However, a limitation was that we used multiple
samples from the 120 women of the Ring Plus study. Ideally, we
should repeat the study in a larger group of women.
Furthermore, although we assessed the association between bac-
terial bioﬁlm and vaginal dysbiosis, more research is needed to
Table 2 Association between the bacterial presence of Atopobium vaginae and Gardnerella vaginalis by fluorescence in situ hybridisation
(FISH) and the vaginal microbiome defined by Nugent scoring
G. vaginalis and
A. vaginae combination absent
G. vaginalis (Gv) or
A. vaginae (Av)
dispersed only
Gv adherent ± Gv
dispersed and Av absent
Gv adherent ± Gv
dispersed and Av dispersed only
Gv and Av adherent ± dispersed
Gv and Av
Total=463 170 101 51 15 126
Nugent 0–3 153 (90) 72 (71.3) 14 (27.5) 3 (20) 17 (13.5)
Nugent 4–10 17 (10) 29 (28.7) 37 (72.5) 12 (80) 109 (86.5)
OR (CI)* Reference 4.5 (2 to 10.3) 49.2 (15.9 to 151.8) 75.6 (13.3 to 429.5) 119 (39.9 to 360.8)
p Value χ2 test* 0.001 <0.001 <0.001 <0.001
*The mixed-effects logistic regression model was adjusted for woman, randomisation group and visit.
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unravel the exact mechanisms of bioﬁlm formation in BV,
including the role and the importance of both bacteria studied,
to ﬁnally deﬁne improved regimens for treatment of BV.
Moreover, since BV is a polymicrobial condition, new research
should study the involvement of other bacteria related to BV.
In conclusion, the presented study uncovered a key piece of
the BV puzzle conﬁrming ﬁrst, the importance of A. vaginae in
BV-associated bioﬁlm and second, showing the joint presence of
A. vaginae and G. vaginalis in a bioﬁlm. Future studies covering
a wide array of BV-associated bacteria may help to further delin-
eate bioﬁlm mechanisms in BV.
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Figure 1 Superimposed confocal
laser scanning images with 400×
magniﬁcation of Atopobium vaginae
+Gardnerella vaginalis bioﬁlm in six
vaginal samples (A–F): vaginal
epithelial cells DAPI in blue, A.
vaginae-speciﬁc peptide nucleic acid
(PNA)-probe AtoITM1 with Alexa Fluor
488 in green and G. vaginalis-speciﬁc
PNA-probe Gard162 with Alexa Fluor
647 in red. For clarity, we omitted the
BacUni-1 plane, such that the bacteria
that did not hybridise with Gard162
and AtoITM1 are visible in DAPI blue
only.
Key messages
▸ This study shows that Atopobium vaginae is an important
constituent of the vaginal bioﬁlm, and is of relevance in the
context of bacterial vaginosis (BV).
▸ We show that A. vaginae is almost always accompanied by
Gardnerella vaginalis in BV, but that G. vaginalis can be
found without A. vaginae in the vaginal microbiome.
▸ By tackling constituents of the bioﬁlm, the above knowledge
can contribute to a more effective and goal-oriented
treatment and improve women’s reproductive health.
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